The unique description of self-limiting myopathy with anti-HMGCR positivity implies novel immunological mechanisms distinct from the traditional paradigm of self-perpetuating autoimmunity and inflammation in the setting of the anti-HMGCR autoantibody. Here, HMGCR is linked to myopathy.